cefuroxime has been researched along with Hypertrophy in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nour, S | 1 |
| MacKinnon, AE | 1 |
| Dickson, JA | 1 |
| Walker, J | 1 |
1 trial available for cefuroxime and Hypertrophy
| Article | Year |
|---|---|
Antibiotic prophylaxis for infantile pyloromyotomy.
Topics: Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Female; Humans; Hypertrophy; Infant; Infant, New | 1996 |